Xinjiang Huasidan Pharmaceutical Research

Xinjiang Huashidan Pharmaceutical Research is the dedicated R&D arm of Xinjiang Huashidan Pharmaceutical Co., Ltd., a prominent pharmaceutical group based in Urumqi, Xinjiang, China. The company specializes in the research and development of traditional Chinese medicines (TCM), ethnic Uighur medicines, and modern chemical drugs, with a focus on respiratory, cardiovascular, and bone health therapeutic areas. Its portfolio features several national-level new drugs, including the patented Ejiao Qianggu Oral Liquid for bone health and a wide range of infusion and oral liquid products. The research institute is recognized as a high-tech enterprise and hosts a post-doctoral research station, actively participating in China's national Major New Drug Creation projects. It integrates advanced manufacturing with scientific innovation to serve domestic and international markets, particularly in Central and South Asia. The company is also involved in the development of Class 1.1 innovative chemical drugs and maintains a strong focus on quality through international GMP standards.